Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
cyclin dependent kinase inhibitor 2A | 0.300 | 0.885 | 0.39 |
|
group | 0.600 | None | 0.946 | 0 | 0 | 1994 | 2020 | ||||||||
|
cyclin dependent kinase inhibitor 2A | 0.300 | 0.885 | 0.39 |
|
disease | 0.600 | None | 0.936 | 0 | 0 | 1994 | 2020 | ||||||||
|
cyclin dependent kinase inhibitor 2A | 0.300 | 0.885 | 0.39 |
|
disease | 0.800 | strong | 0.950 | 0 | 0 | 1994 | 2020 | ||||||||
|
cyclin dependent kinase inhibitor 2A | 0.300 | 0.885 | 0.39 |
|
disease | 0.800 | None | 1.000 | 0 | 0 | 1996 | 2019 | ||||||||
|
cyclin dependent kinase inhibitor 2A | 0.300 | 0.885 | 0.39 |
|
disease | 0.700 | None | 0.949 | 0 | 0 | 1995 | 2016 | ||||||||
|
cyclin dependent kinase inhibitor 2A | 0.300 | 0.885 | 0.39 |
|
disease | 0.600 | None | 0.980 | 0 | 0 | 1995 | 2019 | ||||||||
|
cyclin dependent kinase inhibitor 2A | 0.300 | 0.885 | 0.39 |
|
disease | 0.600 | None | 0.979 | 0 | 0 | 1995 | 2019 | ||||||||
|
cyclin dependent kinase inhibitor 2A | 0.300 | 0.885 | 0.39 |
|
disease | 0.300 | None | 0 | 0 | |||||||||||
|
cyclin dependent kinase inhibitor 2B | 0.417 | 0.769 | 7.3E-03 |
|
group | 0.400 | None | 0.947 | 0 | 0 | 1995 | 2018 | ||||||||
|
cyclin dependent kinase inhibitor 2B | 0.417 | 0.769 | 7.3E-03 |
|
disease | 0.700 | None | 0.882 | 0 | 0 | 1995 | 2019 | ||||||||
|
cyclin dependent kinase inhibitor 2C | 0.527 | 0.654 | 0.40 |
|
group | 0.400 | None | 0.818 | 0 | 0 | 1993 | 2018 | ||||||||
|
cyclin dependent kinase inhibitor 2C | 0.527 | 0.654 | 0.40 |
|
disease | 0.320 | None | 1.000 | 0 | 0 | 2003 | 2013 | ||||||||
|
cyclin dependent kinase inhibitor 2C | 0.527 | 0.654 | 0.40 |
|
disease | 0.340 | None | 1.000 | 0 | 0 | 1997 | 2011 | ||||||||
|
IKAROS family zinc finger 1 | 0.533 | 0.769 | 1.00 |
|
disease | 0.320 | None | 1.000 | 0 | 0 | 2000 | 2017 | ||||||||
|
IKAROS family zinc finger 1 | 0.533 | 0.769 | 1.00 |
|
disease | 0.700 | None | 1.000 | 0 | 0 | 2002 | 2019 | ||||||||
|
DLC1 Rho GTPase activating protein | 0.529 | 0.731 | 1.00 |
|
disease | 0.300 | None | 0 | 0 | |||||||||||
|
CCAAT enhancer binding protein alpha | 0.496 | 0.692 | 0.55 |
|
disease | 1.000 | definitive | 0.985 | 0 | 0 | 1992 | 2020 | ||||||||
|
CCAAT enhancer binding protein alpha | 0.496 | 0.692 | 0.55 |
|
group | 0.400 | None | 0.923 | 0 | 0 | 2002 | 2020 | ||||||||
|
G protein subunit alpha 13 | 0.656 | 0.538 | 0.87 |
|
disease | 0.330 | None | 1.000 | 0 | 0 | 2013 | 2019 | ||||||||
|
stromal antigen 2 | 0.568 | 0.731 | 1.00 |
|
disease | 0.560 | None | 1.000 | 0 | 0 | 2013 | 2018 | ||||||||
|
stromal antigen 2 | 0.568 | 0.731 | 1.00 |
|
disease | 0.570 | None | 1.000 | 0 | 0 | 2013 | 2018 | ||||||||
|
stromal antigen 2 | 0.568 | 0.731 | 1.00 |
|
disease | 0.300 | None | 0 | 0 | |||||||||||
|
stromal antigen 2 | 0.568 | 0.731 | 1.00 |
|
disease | 0.310 | None | 1.000 | 0 | 0 | 2019 | 2019 | ||||||||
|
stromal antigen 2 | 0.568 | 0.731 | 1.00 |
|
disease | 0.330 | None | 1.000 | 0 | 0 | 2012 | 2016 | ||||||||
|
stromal antigen 2 | 0.568 | 0.731 | 1.00 |
|
disease | 0.300 | None | 0 | 0 |